{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:17:11Z","timestamp":1791091031566,"version":"4.1.0"},"reference-count":16,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"published-print":{"date-parts":[[1989,6,1]]},"DOI":"10.1136\/jnnp.52.6.773","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T21:16:40Z","timestamp":1226351800000},"page":"773-775","source":"Crossref","is-referenced-by-count":47,"title":["A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up."],"prefix":"10.1136","volume":"52","author":[{"given":"J L","family":"Montastruc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Rascol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rascol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0031-6997(25)06826-7","article-title":"Bromocriptine in Parkinson's disease","volume":"37","author":"Lieberman, A.N.; Goldstein, M.","year":"1985","unstructured":"Lieberman AN, Goldstein M. Bromocriptine in Parkinson's disease. Pharmacol Rev 1985;37:217-27.","journal-title":"Pharmacol Rev"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/archneur.1988.00520260092026","article-title":"International symposium on early dopamine agonist therapy of Parkinson's disease","volume":"45","author":"Kurlan, R.","year":"1988","unstructured":"Kurlan R. International symposium on early dopamine agonist therapy of Parkinson's disease. Arch Neurol 1988;45:204-8.","journal-title":"Arch Neurol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/jnnp.42.2.143","article-title":"Long term treatment of Parkinson's disease with bromocriptine","volume":"42","author":"Rascol, A.; Guiraud-Chaumeil, B.; Montastruc, J.L.; David, J.; Clanet, M.","year":"1979","unstructured":"Rascol A, Guiraud-Chaumeil B, Montastruc JL, David J, Clanet M. Long term treatment of Parkinson's disease with bromocriptine. J Neurol Neurosurg Psychiatry 1979;42: 143-50.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref_4","first-page":"401","article-title":"La bromocriptine comme premier traitement de la maladie de Parkinson","volume":"138","author":"Rascol, A.; Montastruc, J.L.; Guiraud-Chaumeil, B.; Clanet, M.","year":"1982","unstructured":"Rascol A, Montastruc JL, Guiraud-Chaumeil B, Clanet M. La bromocriptine comme premier traitement de la maladie de Parkinson. Rev Neurol (Paris) 1982;138: 401-8.","journal-title":"Rev Neurol (Paris)"},{"key":"ref_5","first-page":"1","article-title":"Should dopamine agonists be given early or late in the treatment of Parkinson's disease?","volume":"11","year":"1984","unstructured":"Rascol A, Montastruc JL, Rascol 0. Should dopamine agonists be given early or late in the treatment of Parkinson's disease? Can J Neurol Sci 1984;11(suppl 1):229-32.","journal-title":"Can J Neurol Sci"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1212\/WNL.35.8.1196","article-title":"Combined bromocriptine-levodopa therapy early in Parkinson's disease","volume":"35","author":"Rinne, U.K.","year":"1985","unstructured":"Rinne UK. Combined bromocriptine-levodopa therapy early in Parkinson's disease. Neurology 1985;35: 1196-8.","journal-title":"Neurology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00002826-198503000-00007","article-title":"Bromocriptine: problems with low dose de novo therapy in Parkinson's disease","volume":"8","author":"Grimes, J.D.; Delgado, M.R.","year":"1985","unstructured":"Grimes JD, Delgado MR. Bromocriptine: problems with low dose de novo therapy in Parkinson's disease. Clin Neuropharmacol 1985;8:73-7.","journal-title":"Clin Neuropharmacol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00002826-198604000-00004","article-title":"Bromocriptine: long term low-dose therapy in Parkinson's disease","volume":"9","author":"Teychenne, P.F.; Bergsrud, D.; Elton, R.L.; Racy, A.","year":"1986","unstructured":"Teychenne PF, Bergsrud D, Elton RL, Racy A. Bromocriptine: long term low-dose therapy in Parkinson's disease. Clin Neuropharmacol 1986;9: 138-45.","journal-title":"Clin Neuropharmacol"},{"key":"ref_9","first-page":"57680","article-title":"A comparison ofbromocriptine (Parlodel) and levodopacarbidopa (Sinemet) for treatment of \"de novo\"","volume":"14","author":"Libman, I.; Gawel, M.J.; Riopelle, R.J.; Bouchard, S.","year":"1987","unstructured":"Libman I, Gawel MJ, Riopelle RJ, Bouchard S. A comparison ofbromocriptine (Parlodel) and levodopacarbidopa (Sinemet) for treatment of \"de novo\" Parkinson's disease patients. Can JNeurol Sci 1987;14:57680.","journal-title":"Parkinson's disease patients. Can JNeurol Sci"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","year":"1967","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-42.","journal-title":"Neurology"},{"key":"ref_11","first-page":"313","article-title":"The evaluation of extrapyramidal disease","volume-title":"noyaux Gris Centraux et Syndrome de Parkinson","author":"Duvoisin, R.C.","year":"1970","unstructured":"Duvoisin RC. The evaluation of extrapyramidal disease. In: De Ajuriaguerra J, ed. Monoamines: noyaux Gris Centraux et Syndrome de Parkinson. Paris: Masson, 1970:313-25."},{"key":"ref_12","first-page":"25","article-title":"Ergot derivatives for Parkinsonian","volume":"2","author":"Calne, D.B.; Williams, A.C.; Nutt, J.G.","year":"1978","unstructured":"Calne DB, Williams AC, Nutt JG. Ergot derivatives for Parkinsonian. Med J Anesth 1978;2(suppl):25-6.","journal-title":"Med J Anesth"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archneur.1978.00500320023005","article-title":"Bromocriptine in Parkinsonism: a long term study","volume":"35","author":"Lees, A.J.; Haddad, S.; Shaw, K.M.","year":"1978","unstructured":"Lees AJ, Haddad S, Shaw KM. Bromocriptine in Parkinsonism: a long term study. Arch Neurol 1978;35:503-5.","journal-title":"Arch Neurol"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1017\/S0317167100037914","article-title":"Bromocriptine and the clinical spectrum of Parkinson's disease","volume":"14","author":"Riopelle, R.J.","year":"1987","unstructured":"Riopelle RJ. Bromocriptine and the clinical spectrum of Parkinson's disease. Can J Neurol Sci 1987;14:455-9.","journal-title":"Can J Neurol Sci"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0006-8993(86)90783-3","article-title":"Chronic treatment with levodopa, but not bromocriptine, induces dyskinesia in MPTP-Parkinsonian monkeys. Correlation with [3 H]-spiperone binding","volume":"379","author":"Bedard, P.J.; Dipaolo, T.; Falardeau, P.; Boucher, R.","year":"1986","unstructured":"Bedard PJ, Dipaolo T, Falardeau P, Boucher R. Chronic treatment with levodopa, but not bromocriptine, induces dyskinesia in MPTP-Parkinsonian monkeys. Correlation with [3 H]-spiperone binding. Brain Res 1986;379:294-9.","journal-title":"Brain Res"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/0028-3908(87)90008-6","article-title":"Behavioral and biochemical evidence for a different effect of repeated administration of L-Dopa and bromocriptine on denervated versus non denervated striatal dopamine receptors","volume":"26","author":"Rouillard, C.; Bedard, P.J.; Falardeau, P.; Diapaolo, T.","year":"1987","unstructured":"Rouillard C, Bedard PJ, Falardeau P, Diapaolo T. Behavioral and biochemical evidence for a different effect of repeated administration of L-Dopa and bromocriptine on denervated versus non denervated striatal dopamine receptors. Neuropharmacology 1987; 26:1601-6.","journal-title":"Neuropharmacology"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp.52.6.773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T16:44:33Z","timestamp":1738514673000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp.52.6.773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,6,1]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1989,6,1]]}},"URL":"https:\/\/doi.org\/10.1136\/jnnp.52.6.773","relation":{},"ISSN":["0022-3050"],"issn-type":[{"value":"0022-3050","type":"print"}],"subject":[],"published":{"date-parts":[[1989,6,1]]}}}